StockMarketWire.com - Societe Generale today reaffirms its buy investment rating on AstraZeneca PLC [LON:AZN] and raised its price target to 8500p (from 8400p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk